聚化微囊在即时触发释放的生理条件下表现出急剧的pH转变
Viktor Eriksson1, Leyla Beckerman1, Erik Aerts1
1Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 412 96 Gothenburg, Sweden.
Langmuir : the ACS journal of surfaces and colloids
|November 17, 2023
概括
新的pH敏感微囊可以立即释放药物. 这些聚化微囊在暴露于狭窄的pH值变化时,会在几秒钟内释放其整个有效载荷,从而实现快速触发的输送.
科学领域:
- 材料科学 材料科学 材料科学
- 聚合物化学 聚合物化学
- 药物输送系统 药物输送系统
背景情况:
- 刺激反应微囊可控制封装物质的释放.
- 聚化因其可降解性和控制释放应用中的潜力而闻名.
- 在外部刺激下实现瞬间释放仍然是微囊技术的一个挑战.
研究的目的:
- 开发和描述pH控制的刺激反应微囊.
- 为了研究聚化核心外微囊的瞬时释放能力.
- 为了将微囊降解动力学与释放概况相关联.
主要方法:
- 使用聚二二二基酸盐) 作为外材料制备核心外微囊.
- 封装烯作为一个模型活性物质.
- 在狭窄的pH区间内进行pH触发释放研究.
- 使用光谱光度和石英晶体微平衡与散射监测进行降解动力学分析.
主要成果:
- 一个狭窄的触发pH区间 (6.46.9) 被确定为即时释放.
- 整个核心内容在pH值变化后在几秒钟内释放出来.
- 降解动力学与从释放数据中得出的扩散系数有很好的相关性.
- 微囊在温和条件下显示出快速触发释放.
结论:
- 开发的聚化核心外微囊为几乎瞬间触发释放提供了一个平台.
- 对释放的精确控制归因于设计的形态学和材料特性.
- 这些微囊对于需要快速输送活性物质的应用具有前景.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...


